Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Down 9.9% in July

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the target of a significant drop in short interest in the month of July. As of July 15th, there was short interest totalling 2,331,100 shares, a drop of 9.9% from the June 30th total of 2,586,200 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Genomma Lab Internacional Stock Performance

Genomma Lab Internacional stock remained flat at $0.98 during midday trading on Tuesday. Genomma Lab Internacional has a 1 year low of $0.79 and a 1 year high of $0.99. The stock’s fifty day simple moving average is $0.97 and its two-hundred day simple moving average is $0.91.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.